A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding von DeJesus, E, Kieft, R, Albright, B, Stephens, N A, Hajduk, S L

Volltext

Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis von Villanueva, Paulina J, Martinez, Alberto, Baca, Sarah T, DeJesus, Rebecca E, Larragoity, Manuel, Contreras, Lisett, Gutierrez, Denisse A, Varela-Ramirez, Armando, Aguilera, Renato J

Volltext

Final 192‐week efficacy and safety of once‐daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV‐1‐infected treatment‐naïve patients in the ARTEMIS trial von Orkin, C, DeJesus, E, Khanlou, H, Stoehr, A, Supparatpinyo, K, Lathouwers, E, Lefebvre, E, Opsomer, M, Van de Casteele, T, Tomaka, F

Volltext

Switching to coformulated rilpivirine (RPV), emtricitabine (FTC) and tenofovir alafenamide from either RPV, FTC and tenofovir disoproxil fumarate (TDF) or efavirenz, FTC and TDF: 9... von Hagins, D, Orkin, C, Daar, ES, Mills, A, Brinson, C, DeJesus, E, Post, FA, Morales‐Ramirez, J, Thompson, M, Osiyemi, O, Rashbaum, B, Stellbrink, H‐J, Martorell, C, Liu, H, Liu, Y‐P, Porter, D, Collins, SE, SenGupta, D, Das, M

Volltext

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patient... von Campo, R., DeJesus, E., Bredeek, U. F., Henry, K., Khanlou, H., Logue, K., Brinson, C., Benson, P., Dau, L., Wang, H., White, K., Flaherty, J., Fralich, T., Guyer, B., Piontkowsky, D.

Volltext

Novel Oridonin Analog CYD0682 Inhibits Hepatic Stellate Cell Activation via the Heat Shock Protein 90–Dependent STAT3 Pathway von Dejesus, Jana E., Wang, Xiaofu, Gu, Yanping, Zhou, Jia, Radhakrishnan, Ravi S.

Volltext

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase... von Lathouwers, Erkki, Wong, Eric Y., Brown, Kimberley, Baugh, Bryan, Ghys, Anne, Jezorwski, John, Mohsine, El Ghazi, Van Landuyt, Erika, Opsomer, Magda, De Meyer, Sandra, De Wit, S., Florence, E., Vandekerckhove, L., Vandercam, B., Brunetta, J., Klein, M., Murphy, D., Rachlis, A., Walmsley, S., Ajana, F., Cotte, L., Girard, P-M, Katlama, C., Molina, J-M, Poizot-Martin, Raffi, F., Rey, D., Reynes, J., Teicher, E., Yazdanpanah, Y., Arasteh, K., Bickel, M., Bogner, J., Esser, S., Faetkenheuer, G., Jessen, H., Kern, W., Rockstroh, J., Spinner, C., Stellbrink, H-J, Stoehr, A., Antinori, A., Castelli, F., Chirianni, A., De Luca, A., Di Biagio, A., Galli, M., Lazzarin, A., Maggiolo, F., Maserati, R., Mussini, C., Garlicki, A., Gasiorowski, J., Halota, W., Horban, A., Parczewski, M., Piekarska, A., Belonosova, E., Chernova, O., Dushkina, N., Kulagin, Ryamova, E., Shuldyakov, A., Sizova, N., Tsybakova, O., Voronin, E., Yakovlev, A., Antela, A., Arribas, J. R., Berenguer, J., Casado, J., Estrada, Galindo, M. J., Garcia Del Toro, M., Gatell, J. M., Gorgolas, M., Gutierrez, F., Gutierrez, M. D. M., Negredo, E., Pineda, J. A., Podzamczer, D., Portilla Sogorb, J., Rivero, A., Rubio, R., Viciana, P., De Los Santos, Clarke, A., Gazzard, B. G., Johnson, M. A., Orkin, C., Reeves, Waters, L., Benson, P., Bhatti, L., Bredeek, F., Crofoot, G., Cunningham, D., DeJesus, E., Eron, J., Felizarta, F.

Volltext

Field Comparison of Carbon Dioxide Source with Biogents Sentinel-2 and Pro Traps for Adult Aedes Mosquito Surveillance von Cilek, J E, Jiang, Y X, Dejesus, C E

Volltext

A randomised comparison of safety and efficacy of nevirapine vs. atazanavir/ritonavir combined with tenofovir/emtricitabine in treatment-naïve patients von DeJesus, E., Mills, A., Bhatti, L., Conner, C., Storfer, S.

Volltext

The ASSURE study: HIV‐1 suppression is maintained with bone and renal biomarker improvement 48 weeks after ritonavir discontinuation and randomized switch to abacavir/lamivudine + ... von Wohl, DA, Bhatti, L, Small, CB, Edelstein, H, Zhao, HH, Margolis, DA, DeJesus, E, Weinberg, WG, Ross, LL, Shaefer, MS

Volltext

LP04 : A phase 3, open-label, single-arm study to evaluate the efficacy and safety of 12 weeks of simeprevir (SMV) plus sofosbuvir (SOF) in treatment-naïve or -experienced patients... von Lawitz, E, Matusow, G, DeJesus, E, Yoshida, E, Felizarta, F, Ghalib, R, Godofsky, E, Herring, R, Poleynard, G, Sheikh, A, Tobias, H, Kugelmas, M, Kalmeijer, R, Peeters, M, Lenz, O, Fevery, B, De La Rosa, G, Scott, J, Sinha, R, Witek, J

Volltext

Cytokine Pathways in Cardiac Dysfunction following Burn Injury and Changes in Genome Expression von DeJesus, Jana E, Wen, Jake J, Radhakrishnan, Ravi

Volltext

A new pyridazinone exhibits potent cytotoxicity on human cancer cells via apoptosis and poly-ubiquitinated protein accumulation von Gutierrez, Denisse A., DeJesus, Rebecca E., Contreras, Lisett, Rodriguez-Palomares, Isela A., Villanueva, Paulina J., Balderrama, Karol S., Monterroza, Lenore, Larragoity, Manuel, Varela-Ramirez, Armando, Aguilera, Renato J.

Volltext

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment‐naïve HIV‐1‐infected patients von Vrouenraets, SME, Wit, FWNM, Fernandez Garcia, E, Moyle, GJ, Jackson, AG, Allavena, C, Raffi, F, Jayaweera, DT, Mauss, S, Katlama, C, Fisher, M, Slama, L, Hardy, WD, DeJesus, E, van Eeden, A, Reiss, P

Volltext

O63 EFFICACY AND SAFETY OF THE ALL-ORAL REGIMEN, MK-5172/MK-8742 +/− RBV FOR 12 WEEKS IN GT1 HCV/HIV CO-INFECTED PATIENTS: THE C-WORTHY STUDY von Sulkowski, M, Mallolas, J, Pol, S, Bourliere, M, Gerstoft, J, Shibolet, O, Nahass, R, DeJesus, E, Shaughnessy, M, Hwang, P, Wahl, J, Robertson, M.N, Haber, B

Volltext

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised,... von Sax, Paul E, Dr Prof, Wohl, David, MD, Yin, Michael T, Prof, Post, Frank, MD, DeJesus, Edwin, MD, Saag, Michael, MD, Pozniak, Anton, MD, Thompson, Melanie, MD, Podzamczer, Daniel, MD, Molina, Jean Michel, Prof, Oka, Shinichi, MD, Koenig, Ellen, MD, Trottier, Benoit, MD, Andrade-Villanueva, Jaime, MD, Crofoot, Gordon, MD, Custodio, Joseph M, PharmD, Plummer, Andrew, MS, Zhong, Lijie, PhD, Cao, Huyen, MD, Martin, Hal, MD, Callebaut, Christian, PhD, Cheng, Andrew K, MD, Fordyce, Marshall W, MD, McCallister, Scott, MD

Volltext

O165 SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN HCV GENOTYPE 1 PRIOR NULL-RESPONDER/TREATMENT-NAIVE PATIENTS (COSMOS STUDY): PRIMARY ENDPOINT (SVR12) RESULTS IN PATIENTS... von Lawitz, E, Ghalib, R, Rodriguez-Torres, M, Younossi, Z.M, Corregidor, A, Sulkowski, M.S, DeJesus, E, Pearlman, B, Rabinovitz, M, Gitlin, N, Lim, J.K, Pockros, P.J, Fevery, B, Lambrecht, T, Ouwerkerk-Mahadevan, S, Callewaert, K, Symonds, W.T, Picchio, G, Lindsay, K, Beumont-Mauviel, M, Jacobson, I.M

Volltext

Vesatolimod (GS-9620) is safe and pharmacodynamically active in HIV-infected individuals von Riddler, S., Para, M., Benson, C., Mills, A., Ramgopal, M., Dejesus, E., Brinson, C., Cyktor, J., Mellors, J., Guo, S., Doehle, B., Markova, S., Patel, H., Graham, H., Hesselgesser, J., Geleziunas, R., Brainard, D., McCallister, S., Sengupta, D.

Volltext

A Rare Case of Erosive Esophagitis Due to Sarcina Ventriculi Infection von Defilippo, Christine, DeJesus, Jana E, Gosnell, Joseph M, Qiu, Suimin, Humphrey, Laurel

Volltext

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV von Gallant, Joel E, DeJesus, Edwin, Arribas, José R, Pozniak, Anton L, Gazzard, Brian, Campo, Rafael E, Lu, Biao, McColl, Damian, Chuck, Steven, Enejosa, Jeffrey, Toole, John J, Cheng, Andrew K

Volltext